Brief: Ascelia Pharma Q2 EPS at SEK -1.19

Ascelia Pharma AB

18/08/2023 06:31

Aug 18 (Reuters) - Ascelia Pharma Q2 EBIT SEK -41.8 million.
* Q2 EPS SEK -1.19
* Q2 cash flow from operations SEK -42.3 million